-
7/27/2019 Iribarne Et Al;Incremental Cost of Right Ventricular Failure After Left Ventricular Assist Device, JACC, 2011, V57, I17
1/1
E313
JACC April 5, 2011
Volume 57, Issue 17
CARDIAC FUNCTION AND HEART FAILURE
INCREMENTAL COST OF RIGHT VENTRICULAR FAILURE AFTER LEFT VENTRICULAR ASSIST DEVICE
PLACEMENT
ACC Poster ContributionsErnest N. Morial Convention Center, Hall F
Monday, April 04, 2011, 9:30 a.m.-10:45 a.m.
Session Title: Cardiac Tranplantation/Assist Devices -- Basic and ClinicalAbstract Category: 23. Cardiac Transplantation/Assist DevicesBasic and Clinical
Session-Poster Board Number: 1087-4
Authors:Alexander Iribarne, Sang-Woo Pak, Mark J. Russo, Rachel Easterwood, Jonathan Yang, Hiroo Takayama, Donna Mancini, Yoshifumi Naka,Columbia University Medical Center, New York, NY, University of Chicago, Chicago, IL
Background:To quantiy the incremental cost associated with right ventricular ailure (RVF) ater let ventricular assist device (LVAD) placement.
Methods: Data on HeartMate XVE (n=107) and HeartMate II (n=58) LVAD recipients rom 1/1/03-1/1/09 at our institution were retrospectively
reviewed. Total hospital costs were adjusted to post-op costs using multivariable regression and stratifed by billing category (Table 1). Clinical
outcomes included: development o post-op RVF, need or RVAD, ICU length o stay (LOS), and in-hospital mortality.
Results: Among all LVAD recipients, 28.5% (n=47) were diagnosed with post-op RVF, and o these 42.6% (n=20) required an RVAD. RVF was
associated with a mean $89,955 34,279 higher post-op cost o hospitalization (p=0.01). The increased cost o RVF was driven by an increase in
mean direct ($71,375 21,012; p=0.001) versus indirect ($23,007 21,413; p=0.284) costs. RVF requiring insertion o an RVAD was associated
with a $273,619 34,359 higher post-op cost o hospitalization (p